Rheumatoid arthritis is a long-term autoimmune disease that affects millions of people around the world.
Unlike the wear and tear seen in osteoarthritis, rheumatoid arthritis develops when the body’s immune system mistakenly attacks healthy joint tissue.
This causes ongoing inflammation that can lead to pain, swelling, stiffness, and loss of movement.
As the disease progresses, it can damage cartilage and bone, making everyday activities much more difficult. In some people, rheumatoid arthritis can also affect other parts of the body, including the heart, lungs, eyes, and blood vessels.
Although doctors have treated rheumatoid arthritis for many years, scientists still do not fully understand what causes the disease to begin.
Genetics can increase a person’s risk, but genes alone do not explain why the immune system suddenly starts attacking healthy tissue. Researchers believe that environmental factors, infections, smoking, and changes in the bacteria living inside the gut may all play important roles.
Over the past decade, the human gut microbiome has become a major area of medical research. The gut contains trillions of bacteria and other microorganisms that help digest food, produce vitamins, and support the immune system.
Most of these microbes are helpful and are an important part of staying healthy. However, changes in the balance of these bacteria have been linked to several diseases, including obesity, diabetes, inflammatory bowel disease, and autoimmune disorders.
A new study led by Dr. Kristine Kuhn from the University of Colorado and researchers from several other institutions provides some of the strongest evidence yet that one specific type of gut bacteria may help trigger rheumatoid arthritis in people who are already at high risk of developing the disease.
The researchers focused on people who had early warning signs of rheumatoid arthritis but had not yet developed painful or swollen joints.
These individuals already carried certain antibodies in their blood that are known to increase the likelihood of developing the disease in the future. By studying this group, the scientists hoped to identify events that occur before rheumatoid arthritis actually begins.
To investigate, the team collected blood samples and stool samples from these volunteers. They isolated antibodies from the blood and mixed them with bacteria found in the stool samples.
This allowed the researchers to identify which bacteria the immune system was reacting to most strongly. One previously unrecognized bacterial species stood out because the antibodies consistently identified it as a target.
The researchers then tested whether this bacterium could actually trigger disease. They introduced it into the intestines of animal models and carefully monitored what happened. The results were striking.
The animals developed the same early immune markers that are commonly seen in people who are at risk of rheumatoid arthritis. In some cases, the animals later developed symptoms that closely resembled rheumatoid arthritis itself.
The team also examined immune cells known as T cells from people with rheumatoid arthritis. These cells responded strongly when they encountered the newly identified bacterium. In contrast, T cells taken from healthy volunteers showed little or no reaction. This finding suggests that the bacterium may activate an immune response that is unique to people who are susceptible to rheumatoid arthritis.
The discovery is important because it points to a possible trigger that appears before joint damage develops. If future studies confirm these findings, doctors may eventually be able to identify high-risk people and intervene much earlier. Instead of waiting until joints become permanently damaged, treatments could potentially target the bacteria or the immune response it creates before rheumatoid arthritis fully develops.
However, the researchers emphasise that much more work is still needed. The study does not prove that this bacterium is the only cause of rheumatoid arthritis.
The disease is complex and likely results from a combination of genetic, environmental, and immune factors. Scientists must now determine exactly how the bacterium interacts with the immune system and whether removing or controlling it can actually prevent disease in humans.
The research took five years to complete and relied on volunteers who knew they were at increased risk of rheumatoid arthritis and agreed to participate. Their contribution has helped scientists move one step closer to understanding how this disabling disease begins.
The study was led by Dr. Kristine Kuhn and published in the journal Science Translational Medicine. While additional research will be needed before new treatments become available, the findings provide fresh hope that rheumatoid arthritis might one day be prevented before painful symptoms ever appear.
Understanding the relationship between gut bacteria and the immune system could open an entirely new direction for preventing autoimmune diseases.
If you care about health, please read studies about extra virgin olive oil for arthritis, and pomegranate: A natural treatment for rheumatoid arthritis.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing medical cannabis may help reduce arthritis pain, back pain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
